Cocrystal Pharma Inc (COCP) Hedge Fund & Institutional Holdings (Q2 2026)

COCP ranks #7636 out of 37569 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

COCP is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

28 institutions disclose a position in COCP, but none treat it as a major bet — even Ground Swell Capital, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Jim Simons has added to its COCP position for two straight quarters, increasing it by $65.2K to reach $188.6K today.

Tower Research Capital LLC has trimmed its COCP position for two straight quarters, cutting it by $808.0 while still holding $4.2K.

COCP reported a net loss of $9.9M over the trailing twelve months.

• Not yet profitable — net loss of $9.9M over the trailing twelve months
• Revenue grew 46.1% year over year
• Net income improved year over year, from -$12.6M to -$9.9M
• Operating cash flow was negative, using $8.2M in cash
• Current ratio of 3.68x — enough short-term assets to cover short-term liabilities
• Liabilities run 260.08x equity — a highly leveraged balance sheet worth noting